|
Symbol Search
Browse Symbols
My Charts Menu
F.A.Questions
Suggestion Box
Advertising Info
Commodity Charts
Forex Markets
|
Kyverna Therapeutics Inc KYTX
Stock price quote for Kyverna Therapeutics Inc, symbol KYTX, Nasdaq Stock Exchange.
Quote data is updated continously during trading hours.
|
Kyverna Therapeutics Inc Symbol: KYTX Exchange: NSDQ
|
| Most Recent Activity |
Activity Today |
Yearly Statistics |
|
|
|
|
All market data is delayed by 15 minutes.
Stock price quotations are updated continuously. Click reload to refresh this display.
[Daily],
[Weekly]
and [Monthly] stock price charts are available for Kyverna Therapeutics Inc
Most Recent HeadlinesIPR: Dec 20th, 2024, 16:27Length: 4852 CLASS ACTION NOTICE FOR KYTX: Kessler Topaz Meltzer & Check, LLP Reminds Kyverna Therapeutics, Inc. Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors with Losses to Contact the FirmMNA: Dec 15th, 2024, 21:50Length: 6102 KYTX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces That Kyverna Therapeutics, Inc. Investors With Substantial Losses Have Opportunity To Lead Class Action LawsuitMNA: Dec 15th, 2024, 20:54Length: 6102 KYTX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces That Kyverna Therapeutics, Inc. Investors With Substantial Losses Have Opportunity To Lead Class Action LawsuitMNA: Dec 15th, 2024, 20:00Length: 6102 KYTX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces That Kyverna Therapeutics, Inc. Investors With Substantial Losses Have Opportunity To Lead Class Action LawsuitMNA: Dec 15th, 2024, 19:06Length: 6102 KYTX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces That Kyverna Therapeutics, Inc. Investors With Substantial Losses Have Opportunity To Lead Class Action LawsuitMNA: Dec 15th, 2024, 18:13Length: 6102 KYTX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces That Kyverna Therapeutics, Inc. Investors With Substantial Losses Have Opportunity To Lead Class Action LawsuitMNA: Dec 15th, 2024, 17:21Length: 6102 KYTX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces That Kyverna Therapeutics, Inc. Investors With Substantial Losses Have Opportunity To Lead Class Action LawsuitMNA: Dec 15th, 2024, 16:31Length: 6102 KYTX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces That Kyverna Therapeutics, Inc. Investors With Substantial Losses Have Opportunity To Lead Class Action LawsuitMNA: Dec 15th, 2024, 15:33Length: 6102 KYTX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces That Kyverna Therapeutics, Inc. Investors With Substantial Losses Have Opportunity To Lead Class Action LawsuitMNA: Dec 15th, 2024, 14:40Length: 6102 KYTX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces That Kyverna Therapeutics, Inc. Investors With Substantial Losses Have Opportunity To Lead Class Action Lawsuit
Market data delivered to TradingCharts.com, Inc. by Barchart.com.
Although it is believed that information provided is accurate, no guarantee is made.
|
|
